Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shares shot up 16.3% during mid-day trading on Thursday . The company traded as high as $5.45 and last traded at $2.50. 470 shares changed hands during trading, a decline of 68% from the average session volume of 1,459 shares. The stock had previously closed at $2.15.
Silence Therapeutics Stock Up 16.3 %
The stock has a 50 day moving average of $5.71 and a 200 day moving average of $6.47.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Read More
- Five stocks we like better than Silence Therapeutics
- How to Start Investing in Real Estate
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use the MarketBeat Dividend Calculator
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Use Stock Screeners to Find Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
